Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-07-05 Shawver Laura Director Sale −31,112 $6.41 $200K 210,346
2023-07-05 Shawver Laura Director Exercise or conversion · Stock Option (Right to Buy) −31,112 145,365
2023-07-03 Shawver Laura Director Exercise or conversion +26,520 $1.27 $34K 236,866
2023-07-03 Shawver Laura Director Sale −26,520 $6.73 $178K 210,346
2023-07-03 Shawver Laura Director Exercise or conversion · Stock Option (Right to Buy) −26,520 176,477
2023-06-27 Dadoo Rajeev Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-27 Kelly Michael Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-27 Shah Pratik Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-27 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-27 Shawver Laura Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-27 SAUNDERS BRENT L Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-27 SCHNEIDER PHILLIP M Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-27 Islam Saqib Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-06-27 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2023-06-02 Shawver Laura Director Exercise or conversion 10b5-1 +26,941 $1.27 $34K 237,287
2023-06-02 Shawver Laura Director Sale 10b5-1 −26,941 $6.95 $187K 210,346
2023-06-02 Shawver Laura Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −26,941 202,997
2023-06-01 Shawver Laura Director Exercise or conversion 10b5-1 +73,059 $1.27 $93K 283,405
2023-06-01 Shawver Laura Director Sale 10b5-1 −73,059 $6.80 $497K 210,346
2023-06-01 Shawver Laura Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −73,059 229,938

Page 22 of 31 · 602 trades